Detalhe da pesquisa
1.
The local microenvironment drives activation of neutrophils in human brain tumors.
Cell
; 186(21): 4546-4566.e27, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769657
2.
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.
Cell
; 181(7): 1643-1660.e17, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32470396
3.
Progressive deafness-dystonia due to SERAC1 mutations: A study of 67 cases.
Ann Neurol
; 82(6): 1004-1015, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29205472
4.
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Cell Rep Med
; 4(1): 100900, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652909
5.
Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation.
Nat Cancer
; 4(6): 908-924, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217652
6.
An integrated pipeline for comprehensive analysis of immune cells in human brain tumor clinical samples.
Nat Protoc
; 16(10): 4692-4721, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462595
7.
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis.
Nat Cancer
; 2(10): 1086-1101, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121879
8.
SUCLA2 Deficiency: A Deafness-Dystonia Syndrome with Distinctive Metabolic Findings (Report of a New Patient and Review of the Literature).
JIMD Rep
; 27: 27-32, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409464